Zhang Ping

Director at Quartzsea Acquisition Corp · on record since Mar 28, 2025
Director at Pelican Acquisition Corp · on record since Jun 3, 2025
Director at Quantumsphere Acquisition Corp · on record since Aug 11, 2025
Chairman, CEO, and CFO at Quantumsphere Acquisition Corp · on record since Aug 11, 2025
Director at GalaxyEdge Acquisition Corp · on record since Apr 6, 2026
Chairman, CEO, and CFO at GalaxyEdge Acquisition Corp · on record since Apr 6, 2026
Director at QuasarEdge Acquisition Corp · on record since Apr 21, 2026
Director at GYRE THERAPEUTICS, INC. · on record since May 20, 2026
Director at FIRST FINANCIAL BANCORP /CA/ · on record since Jul 24, 2019
Director at OceanLight Acquisition Corp · on record since Sep 8, 2026
Chairman, CEO and CFO at OceanLight Acquisition Corp · on record since Sep 8, 2026
10% owner at OceanLight Acquisition Corp · on record since Sep 8, 2026

Insider trading activity of Zhang Ping

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
GYRE THERAPEUTICS, INC.Listing on record	Jun 30, 2026	AwardD (derivative)	40,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	May 20, 2026	OtherD (derivative)	-250,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Jan 9, 2026	AwardD (derivative)	100,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Aug 7, 2025	AwardD (derivative)	250,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	May 28, 2025	AwardD (derivative)	250,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Jan 7, 2025	AwardD (derivative)	52,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Value · USD	Src
GYRE THERAPEUTICS, INC.Listing on record	Jun 30, 2026	AwardD (derivative)	40,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	May 20, 2026	OtherD (derivative)	-250,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Jan 9, 2026	AwardD (derivative)	100,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Aug 7, 2025	AwardD (derivative)	250,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	May 28, 2025	AwardD (derivative)	250,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GYRE THERAPEUTICS, INC.Listing on record	Jan 7, 2025	AwardD (derivative)	52,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC